Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $3,947 - $6,219
3,724 Added 19.72%
22,606 $26,000
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $5,155 - $7,324
4,092 Added 27.67%
18,882 $31,000
Q3 2023

Nov 09, 2023

BUY
$1.61 - $2.54 $5,622 - $8,869
3,492 Added 30.91%
14,790 $26,000
Q2 2023

Aug 11, 2023

BUY
$1.14 - $1.95 $12,879 - $22,031
11,298 New
11,298 $21,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $11.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.